[Recombinant human granulocyte-colony stimulating factor (rhG-CSF) treatment for spleen abscess and periostitis in a patient with chronic granulomatous disease].
A 9-year-old boy with chronic granulomatous disease was hospitalized on May, 1991, because of continued fever and pain in the right elbow. Increased bone intensity at the distal end of right humerus on x-ray and a 33 x 36 mm space-occupying lesion in the spleen on abdominal CT scan were recognized. Under a diagnosis of periosteitis and spleen abscess, intravenous infusion of rhG-CSF at a dose of 200 micrograms/m2/day was started in combination with antimicrobial therapy. Fever, tenderness, swelling in the right elbow and inflammatory indices improved three weeks after the institution of therapy. Hydrogen peroxide (H2O2) formation by neutrophil increased significantly, although intermittently, during the therapy. The spleen abscess had completely vanished on CT scan on February, 1992. The therapy was well tolerated and no significant side effects were observed. The use of rhG-CSF in combination with potent antibiotics is recommended for patients with serious infections in chronic granulomatous disease to avoid a fatal course.
D000038:Abscess / Q000628:therapy*; D001398:Aztreonam / Q000008:administration & dosage / Q000031:analogs & derivatives; D015296:Ceftizoxime / Q000008:administration & dosage / Q000031:analogs & derivatives; D002648:Child; D002701:Chloramphenicol / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006105:Granulomatous Disease, Chronic / Q000150:complications*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010522:Periostitis / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013158:Splenic Diseases / Q000628:therapy*
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C044145:carumonam; D002701:Chloramphenicol; C049934:cefuzonam; D015296:Ceftizoxime; D001398:Aztreonam